For: | Hayward KL, Valery PC, Martin JH, Karmakar A, Patel PJ, Horsfall LU, Tallis CJ, Stuart KA, Wright PL, Smith DD, Irvine KM, Powell EE, Cottrell WN. Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis. World J Gastroenterol 2017; 23(40): 7321-7331 [PMID: 29142479 DOI: 10.3748/wjg.v23.i40.7321] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i40/7321.htm |
Number | Citing Articles |
1 |
Seyed Mohsen Dehghani, Alireza Shamsaeefar, Azar Kazemi, Kourosh Kazemi, Amirali Mashhadiagha, Seyed Ali Moosavi, Nasrin Motazedian, Saman Nikeghbalian, Seyed Ali Malekhosseini. Medication Non-adherence Prevalence and Determinants in Children and Adolescents with Chronic Liver Diseases. Iranian Journal of Pediatrics 2021; 31(3) doi: 10.5812/ijp.112323
|
2 |
Kuo-Yu Fu, Meng-Lun Hsieh, Jou-An Chen, Vivian Chia-Rong Hsieh. Association between medication adherence and disease outcomes in patients with hepatitis B-related cirrhosis: a population-based case–control study. BMJ Open 2022; 12(6): e059856 doi: 10.1136/bmjopen-2021-059856
|
3 |
Juveriya Farooq, M.M. Sana, P.M. Chetana, Mansour Almuqbil, Nagapati Prabhakar Bhat, Rokeya Sultana, UmaimaFarheen Khaiser, Syed Mohammed Basheeruddin Asdaq, Mutlaq Eidhah M. Almalki, Amro Mohammed sawadi Khormi, Salem Ahmad Albraiki, Moneer E. Almadani. Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life. Saudi Pharmaceutical Journal 2023; 31(8): 101668 doi: 10.1016/j.jsps.2023.06.001
|
4 |
Na Wang, Pei Li, Dandan Suo, Hongyan Wei, Huanhuan Wei, Run Guo, Wen Si. A Predictive Model for Identifying Low Medication Adherence Among Patients with Cirrhosis. Patient Preference and Adherence 2023; : 2749 doi: 10.2147/PPA.S426844
|
5 |
Kohilan Gananandan, Konstantin Kazankov, Elliot B Tapper, Rajeshwar P Mookerjee. The new digital era in decompensated cirrhosis. The Lancet Digital Health 2025; 7(1): e54 doi: 10.1016/S2589-7500(24)00174-2
|
6 |
Joao Miguel Serigado, Katherine C. Barboza, Paula Marcus, Samuel H. Sigal. Clinical Impact of Depression in Cirrhosis. Current Hepatology Reports 2018; 17(1): 22 doi: 10.1007/s11901-018-0386-x
|
7 |
Leen Z. Hasan, George Y. Wu. Novel Agents in the Management of Hepatic Encephalopathy: A Review. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00102
|
8 |
Kelly L. Hayward, Preya J. Patel, Patricia C. Valery, Leigh U. Horsfall, Catherine Y. Li, Penny L. Wright, Caroline J. Tallis, Katherine A. Stuart, Katharine M. Irvine, W. Neil Cottrell, Jennifer H. Martin, Elizabeth E. Powell. Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention. Hepatology Communications 2019; 3(5): 620 doi: 10.1002/hep4.1334
|
9 |
Kristen R. Fox, Rose Y. Hardy, Philip Moons, Adrienne H. Kovacs, Koen Luyckx, Silke Apers, Stephen C. Cook, Gruschen Veldtman, Susan M. Fernandes, Kamila White, Shelby Kutty, Jamie L. Jackson. Smoking among adult congenital heart disease survivors in the United States: Prevalence and relationship with illness perceptions. Journal of Behavioral Medicine 2021; 44(6): 772 doi: 10.1007/s10865-021-00239-5
|
10 |
Hak Keith Leung, Sanjiv Mahadeva, Ruveena Bahavani Rajaram, Pauline Siew Mei Lai. Development and validation of the Adult cirrhosiS Knowledge Questionnaire. European Journal of Gastroenterology & Hepatology 2023; 35(3): 333 doi: 10.1097/MEG.0000000000002493
|
11 |
Maridi Aerts, Zenzi Rosseel, Elisabeth De Waele. The Evolution in Non-Alcoholic Fatty Liver Disease Patients’ Profile and the Associated Sustainable Challenges: A Multidisciplinary Perspective. Nutrients 2024; 16(11): 1584 doi: 10.3390/nu16111584
|
12 |
Kelly L. Hayward, Rianne A. Weersink. Improving Medication‐Related Outcomes in Chronic Liver Disease. Hepatology Communications 2020; 4(11): 1562 doi: 10.1002/hep4.1612
|
13 |
Xiaona Wu, Fang Tang, Huanhuan Li, Cuiqing Chen, Haiyan Zhang, Xiuzhu Liu, Huijing Lai, Qiang Li, Lili Deng, Zengjie Ye. Development and validation of a nomogram model for medication non-adherence in patients with chronic kidney disease. Journal of Psychosomatic Research 2023; 171: 111385 doi: 10.1016/j.jpsychores.2023.111385
|
14 |
Anna-Lena Ehmann, Emily Schütte, Janina Semmler, Felix Berger, Ulrike M. M. Bauer, Katharina Schmitt, Constanze Pfitzer, Paul C. Helm. Key Factors of Adherence in Cardiological Follow-Up of Adults with Congenital Heart Disease. Journal of Cardiovascular Development and Disease 2025; 12(2): 39 doi: 10.3390/jcdd12020039
|
15 |
Yang An, Xiangbo Xu, Tianshu Ren, Zhenhua Tong, Fernando Gomes Romeiro, Andrea Mancuso, Xiaozhong Guo, Xingshun Qi. Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients. International Journal of General Medicine 2021; : 6713 doi: 10.2147/IJGM.S326192
|
16 |
Kathleen P Ismond, Jude A Spiers, Puneeta Tandon. Identifying opportunities for hepatic encephalopathy self-management: A mixed methods systematic review and synthesis. Canadian Liver Journal 2023; 6(2): 215 doi: 10.3138/canlivj-2022-0025
|
17 |
Michał Seweryn Karbownik, Beata Jankowska-Polańska, Robert Horne, Karol Maksymilian Górski, Edward Kowalczyk, Janusz Szemraj, Wen-Jun Tu. Adaptation and validation of the Polish version of the Beliefs about Medicines Questionnaire among cardiovascular patients and medical students. PLOS ONE 2020; 15(4): e0230131 doi: 10.1371/journal.pone.0230131
|
18 |
Novel Drugs for the Management of Hepatic Encephalopathy: Still a Long Journey to Travel. Journal of Clinical and Experimental Hepatology 2022; 12(4): 1200 doi: 10.1016/j.jceh.2022.01.012
|
19 |
Gianni TESTINO, Luigi C. BOTTARO, Enzo ANDORNO, Fabio BANDINI, Patrizia BALBINOT, Sabrina BELTRAMINI, Simona BOTTINO, Marta CALTABELLOTTA, Fabio CAPUTO, Enrica CAVIGLIA, Pierfrancesco CURONE, Antonio DI BIAGIO, Carmelo GAGLIANO, Nicoletta GANDOLFO, Luca PESTARINO, Alessandro ROLLERO, Emanuele ROMAIRONE, Lorenzo SAMPIETRO, Enrico TORRE, Silvia ZUCCARELLI, Rinaldo PELLICANO. Hepatic encephalophaty: management and diagnostic therapeutic assistance path of Ligurian Local Health Company 3 (ASL3). Minerva Medica 2023; 114(5) doi: 10.23736/S0026-4806.22.08408-7
|
20 |
Kelly L. Hayward, Patricia C. Valery, Preya J. Patel, Leigh U. Horsfall, Penny L. Wright, Caroline J. Tallis, Katherine A. Stuart, Michael David, Katharine M. Irvine, W. Neil Cottrell, Jennifer H. Martin, Elizabeth E. Powell. Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis. Internal Medicine Journal 2020; 50(9): 1142 doi: 10.1111/imj.14986
|
21 |
Lubomir Skladany, Jana Vnencakova, Lukas Laffers, Beata Skvarkova, Eva Hrubá, Pavol Molcan, Tomas Koller. Adherence to Oral Nutritional Supplements After Being Discharged from the Hospital is Low but Improves Outcome in Patients with Advanced Chronic Liver Disease. Patient Preference and Adherence 2021; : 2559 doi: 10.2147/PPA.S283034
|
22 |
Silvia Sovaila, Adrian Purcarea, Dan Gheonea, Tudorel Ciurea. Specific Factors That Influence Adherence to Beta Blocker Treatment in Primary Prevention of Variceal Bleeding in Cirrhotic Romanian Patients. a Proof of Concept Qualitative Study. Journal of Medicine and Life 2018; 11(4): 355 doi: 10.25122/jml-2018-1006
|
23 |
Catherine T. Frenette, Cynthia Levy, Sammy Saab. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door. Digestive Diseases and Sciences 2022; 67(6): 1994 doi: 10.1007/s10620-021-07075-2
|